Regardless of the debate, utilizing a TNBS-induced colitis mouse model (BALB/c) demonstrated that IL-33 may accelerate the transition from Th1 to Th2 response, ultimately relieving Th1-type inflammation [14]. The gene discussed is IL33; the disease is colitis.